Intra-Cellular Therapies
ITCI
#1295
Rank
NZ$24.27 B
Marketcap
$228.33
Share price
-0.08%
Change (1 day)
115.86%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : NZ$0.37 Billion

According to Intra-Cellular Therapies's latest financial reports the company's total liabilities are NZ$0.37 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Intra-Cellular Therapies - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.38 B78.97%
2023-12-31NZ$0.21 B39.21%
2022-12-31NZ$0.15 B47.43%
2021-12-31NZ$0.10 B25.87%
2020-12-31NZ$83.78 M0.44%
2019-12-31NZ$83.41 M41.68%
2018-12-31NZ$58.87 M145.24%
2017-12-31NZ$24 M24.09%
2016-12-31NZ$19.34 M68.45%
2015-12-31NZ$11.48 M-14.76%
2014-12-31NZ$13.47 M62.02%
2013-12-31NZ$8.31 M140.93%
2013-03-31NZ$0.03 M
2012-12-31NZ$3.45 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$5.86 M-98.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$89.07 M-76.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.48 B 27.22%๐Ÿ‡บ๐Ÿ‡ธ USA